Study shows Novartis drug Afinitor® plus hormonal therapy delays disease progression in advanced metastatic breast …

Study shows Novartis drug Afinitor® plus hormonal therapy delays disease progression in advanced metastatic breast …
Novartis International AG / Study shows Novartis drug Afinitor® plus hormonal therapy delays disease progression in advanced metastatic breast cancer patients Processed and transmitted by Thomson Reuters. The issuer is solely responsible for the …
Read more on wallstreet:online AG

Lindsay Lohan: Rehab Security Ripped Lohan Off
Lindsay Lohan is almost done with her time at the Betty Ford Center for treatment of her alleged drug addiction. Reports indicate that Lohan is upset and feels that she has been ripped off by security that she had to hire while she has been in treatment at Betty Ford. Sources told TMZ.com that the security was showing up regularly late and she felt she was
Read more on ThirdAge

NICE Says Patient Benefits Of Breast Cancer Drug Are Too Small To Justify Its Very High Cost
The National Institute for Health and Clinical Excellence (NICE) has been asked to assess whether bevacizumab (Avastin, Roche Products), when used in combination with a taxane (a type of chemotherapy), would be a useful and cost-effective treatment option for people with breast cancer which has spread to other parts of the body. In final draft guidance published today (8 December) NICE does not …
Read more on Medical News Today